Jing Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jing Ma has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Boksik Cha
Oklahoma Medical Research Foundation
1 shared publication - Debbie J Mustacich
University of Arizona
1 shared publication - Dongwon Choi
University of Southern California
1 shared publication - Gaurav Kumar Varshney
Genes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
1 shared publication - Greggory Myers
Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI
1 shared publication - Hong Chen
Vascular Biology Program, Boston Children’s Hospital, Boston, Massachusetts, USA
1 shared publication
Latest Publications
- Open Access
GATA2 controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through miR-126
Mutations in the transcription factor GATA2 cause lymphedema. GATA2 is necessary for the development of lymphatic valves (LVs) and lymphovenous valves (LVVs), and for the patterning of lymphatic vessels. Here, we report that GATA2 is not necessary for valvular endothelial cell (VEC) differentiation. Instead, GATA2 is required for VEC maintenance and morphogenesis. GATA2 is also necessary for the expression of cell junction molecules VE-Cadherin and Claudin5 in lymphatic vessels. We identified miR-126 as a target of GATA2, and miR-126 −/− embryos recapitulate the phenotypes of mice lacking GATA2. Primary human lymphatic endothelial cells (HLECs) lacking GATA2 (GATA2 ΔHLEC ) have altered expression of Claudin5 and VE-Cadherin, and blocking miR-126 activity in HLECs phenocopies these changes in expression. Importantly, overexpression of miR-126 in GATA2 ΔHLEC significantly rescues the cell junction defects. Thus, our work defines a new mechanism of GATA2 and uncovers miR-126 as a novel regulator of mammalian lymphatic vascular development. Non-standard abbreviations: LECs , lymphatic endothelial cells; LVs , lymphatic valves; LV-ECs , lymphatic valve-forming endothelial cells; LVVs , lymphovenous valves; LVV-ECs , lymphovenous valve-forming endothelial cells; HLEC , primary human LECs; OSS , Oscillatory shear stress; IHC , immunohistochemistry.
Open AccessGATA2 controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through miR-126
Mutations in the transcription factor GATA2 cause lymphedema. GATA2 is necessary for the development of lymphatic valves (LVs) and lymphovenous valves (LVVs), and for the patterning of lymphatic vessels. Here, we report that GATA2 is not necessary for valvular endothelial cell (VEC) differentiation. Instead, GATA2 is required for VEC maintenance and morphogenesis. GATA2 is also necessary for the expression of cell junction molecules VE-Cadherin and Claudin5 in lymphatic vessels. We identified miR-126 as a target of GATA2, and miR-126 −/− embryos recapitulate the phenotypes of mice lacking GATA2. Primary human lymphatic endothelial cells (HLECs) lacking GATA2 (GATA2 ΔHLEC ) have altered expression of Claudin5 and VE-Cadherin, and blocking miR-126 activity in HLECs phenocopies these changes in expression. Importantly, overexpression of miR-126 in GATA2 ΔHLEC significantly rescues the cell junction defects. Thus, our work defines a new mechanism of GATA2 and uncovers miR-126 as a novel regulator of mammalian lymphatic vascular development. Non-standard abbreviations: LECs , lymphatic endothelial cells; LVs , lymphatic valves; LV-ECs , lymphatic valve-forming endothelial cells; LVVs , lymphovenous valves; LVV-ECs , lymphovenous valve-forming endothelial cells; HLEC , primary human LECs; OSS , Oscillatory shear stress; IHC , immunohistochemistry.